Tackling sepsis and the role of antimicrobial stewardship

Each year, World Sepsis Day takes place on 13 September, an initiative by the Global Sepsis Alliance. Sepsis is a major healthcare challenge, with 47 to 50 million sepsis cases per year; 1 in 5 deaths worldwide are associated with sepsis, while 40% of cases are children under five years old.¹ At the same time, another major healthcare challenge is looming – the World Health Organization (WHO) declared antimicrobial resistance (AMR) as one of the top 10 global public health threats, and AMR is listed on the UK Government’s National Risk Register. Predictions suggest that more than 39 million people around the world could die from antibiotic-resistant infections over the next 25 years.² 

To tackle these interlinked challenges, we need to address the critical intersection of sepsis and antimicrobial stewardship. Getting the basics right will be vital and experts gathered at the symposium to discuss a range of issues – from the difficulties of spotting sepsis in busy emergency departments, to achieving antibiotic stewardship in difficult groups. The speakers highlighted the need to address the challenges encountered when integrating new technologies into our current healthcare system – while innovations in diagnostics and treatments offer hope, their impact is often undermined by fractured infrastructure, limited accessibility, and inconsistent policies. 

Using blood cultures as an example, best practices for collection are crucial before meaningful improvements can take place later in the pathway. It is clear that without getting the basics right first, and addressing foundational system failures, technology alone cannot effectively tackle global health issues like Sepsis and AMR.